Evaluating Tissue-Specific Recombination in a Pdgfrα-CreERT2 Transgenic Mouse Line.
In the central nervous system (CNS) platelet derived growth factor receptor alpha (PDGFRα) is expressed exclusively by oligodendrocyte progenitor cells (OPCs), making the Pdgfrα promoter an ideal tool for directing transgene expression in this cell type. Two Pdgfrα-CreERT2 mouse lines have been gene...
Main Authors: | Megan O'Rourke, Carlie L Cullen, Loic Auderset, Kimberley A Pitman, Daniela Achatz, Robert Gasperini, Kaylene M Young |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5023134?pdf=render |
Similar Items
-
Warning regarding hematological toxicity of tamoxifen activated CreERT2 in young Rosa26CreERT2 mice
by: Martina Rossi, et al.
Published: (2023-04-01) -
Tamoxifen-independent Cre-activity in SMMHC-CreERT2 mice
by: L.B. Steffensen, et al.
Published: (2022-04-01) -
Split-CreERT2: temporal control of DNA recombination mediated by split-Cre protein fragment complementation.
by: Johannes Hirrlinger, et al.
Published: (2009-12-01) -
Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia
by: Kaiser, Tobias, et al.
Published: (2020) -
In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control.
by: Anastasia Felker, et al.
Published: (2016-01-01)